Physician
Nephrology
Dr. Dean A. Kujubu, MD
|
|
Give Review
Doctor Dean A. Kujubu, MD practices Nephrology. He graduated from David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA has a rank of 13 in research and a 7 in primary care He received awards:"Meaningful Use Stage 1 Certification" and "Diabetes Recognition Program". Dean Kujubu is also a published doctor. He has 36 paper published. The most recent paper is: A serum-free in vitro model of renal microvessel development.
Publications
- 25-hydroxyvitamin D levels and Hypertension rates.
- Systemic mastocytosis presenting with Acute oliguric renal failure: report of a case and review of the literature.
- Hyponatremia in a patient With cryptococcal meningitis: syndrome of inappropriate antidiuretic hormone (SIADH) or cerebral salt wasting (CSW)?
- Hyponatremia-what is cerebral salt wasting?
- Sleep apnea in early and advanced chronic Kidney disease: Kaiser Permanente Southern California cohort.
- Evaluation of hypertension With hypokalemia.
- Comparison of outcomes of peritoneal dialysis catheters placed by the fluoroscopically guided percutaneous method versus directly visualized surgical method.
- Evaluation of nocturia in the elderly.
- An overview of nocturia and the Syndrome of nocturnal polyuria in the elderly.
- Spontaneous retroperitoneal hemorrhage due to acquired cystic Kidney disease.
- Prevalence of nondiabetic Renal disease in diabetic patients.
- Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
- A serum-free in vitro model of Renal microvessel development.
- Hypokalemia and the pathology of ion transport molecules.
- The mouse macrophage activation-associated marker protein, p71/73, is an inducible prostaglandin endoperoxide synthase (cyclooxygenase).
- Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells.
- Chromosomal organization of the inducible and constitutive prostaglandin synthase/cyclooxygenase genes in mouse.
- TIS10, a mitogen-inducible glucocorticoid-inhibited gene that encodes a second prostaglandin synthase/cyclooxygenase enzyme.
- Early Responses of PC-12 cells to NGF and EGF: effect of K252a and 5'-methylthioadenosine on gene expression and membrane protein methylation.
- Transforming growth factor beta 1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in Swiss 3T3 cells an...
- The tis genes, primary Response genes induced by growth factors and tumor promoters in 3T3 cells.
- Induction of transiently expressed genes in PC-12 pheochromocytoma cells.
- Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-Response TIS genes in both prolifera...
- Physiology and cell biology update: polypeptide growth factors and their relation to Renal disease.
- Primary response gene expression in Renal hypertrophy and hyperplasia: evidence for different growth initiation processes.
- Differences in "primary response" gene expression in Renal compensatory hypertrophy and hyperplasia.
- Differential induction of primary-Response (TIS) genes in PC12 pheochromocytoma cells and the unresponsive variant PC12nnr5.
- Structure and expression of TIS21, a primary Response gene induced by growth factors and tumor promoters.
- TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.
- Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.
- Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.
- The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary Response genes in UMR 106-01 osteoblast-like c...
- Vitamin D deficiency and anemia: a cross-sectional study.
- Association of race, heart failure and chronic Kidney disease.
- Vitamin D supplementation and recombinant human erythropoietin utilization in Vitamin D-deficient hemodialysis patients.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
Lac UCLA Med Center
La Co Harbor UCLA Med Center
UCLA Med Center
UCLA School Med
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Chronic Glomerulonephritis
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Diabetes Recognition Program
Education
-
UCLA Medical Center -
Harbor - UCLA Medical Center -
David Geffen School of Medicine at UCLA
Helpful Reviews
Similar Doctors
|
Dr. Ryszard Dudek, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Rushdy M. Al-Moomen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Kopelman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sinjoo T. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Raffi B. Merjanian, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott A. Rasgon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susy C. Peng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John J. Sim, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susan Z. Sun, MD |
|
Dr. Larry L. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory Krastein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas O. Pitts, MD |
|
|
Dr. Annie Y. Suh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Hock H. Yeoh, MD
This Doctor is OpenDoctor Recommended.
|